Opentrons® Launches Automation Marketplace to Expand Lab Robotics Accessibility and Streamline Drug Discovery and Microbiome Research

Automation marketplace extends functionality of Opentrons' automated lab robotics by integrating software and hardware offerings from Opentrons' commercial partners

First marketplace partners include research platform and technology companies Cerillo, Genie Life Sciences, and Byonoy

BROOKLYN, N.Y.--(BUSINESS WIRE)--Opentrons Labworks, Inc., a leader in lab automation and makers of accessible lab robotics, today announced the launch of its automation marketplace, with tools and software from Opentrons’ partners that can be easily integrated into Opentrons robotics systems, catering to rapidly expanding sectors like drug discovery and microbiome research. Designed to streamline the research process and enable scientists to concentrate on making impactful discoveries, the marketplace functions as a comprehensive eCommerce hub, enabling customers to effortlessly access essential products, services, and support from Opentrons' commercial partners.

“Each area of research presents unique needs, offering an opportunity for companies to creatively address and cater to the diverse spectrum of required products and services,” said Jonathan Brennan-Badal, CEO of Opentrons. “The diverse range of applications and the flexibility offered by Opentrons' open-source robotics platform, combined with strategic partner technologies catering to various needs, empowers global labs to innovate and automate effectively.”

Opentrons’ automation marketplace will feature hardware, software, and consumables coupled with user documentation and verified protocols to support seamless integration into Opentrons robots, including Opentrons Flex™ and OT-2, extending their functionality. The first marketplace partners include research platform and technology companies Cerillo, Genie Life Sciences, and Byonoy.

Cerillo and Opentrons are automating and optimizing microbiome research and discovery of microbiome therapeutics by integrating Cerillo’s plate readers onto the OT-2 and Flex deck, facilitating efficient experimental setups, including bacterial co-culture studies with Cerillo's specialized plates. Cerillo's research platform provides a comprehensive solution for microorganism growth curve studies through compact microplate readers, ideal for setup in shared modular benchtops, incubators, and anaerobic chambers.

Genie Life Sciences has developed new lab execution software known as Genie LabOS, a user-friendly platform built for simplifying lab automation workflows. When paired with Opentrons Flex or OT-2, Genie LabOS streamlines workflow design, coordination, and execution, providing comprehensive control, experiment planning, and data management. The integration allows users to author, modify, and run scientific protocols, configure instrument-specific settings, and set up coordinated workcells with Opentrons instruments and integrated modules.

Byonoy and Opentrons have partnered to provide modules for the Opentrons Flex, starting with the Byonoy’s gripper-compatible Absorbance 96 Automate on-deck microplate reader, which offers best-in-class read times under five seconds and up to six configurable wavelengths ranging from 400-1000 nm. Along with user-friendly, automated protocols and services, these newly integrated on-deck modules will help support high-throughput applications including protein assays and cell viability workflows.

“Our newly launched automation marketplace serves as a one-stop-shop, providing convenient access to products and services from our partners, who share a commitment to advancing impactful science. Embracing the principles of open-source science, we aim to continually expand our marketplace offerings through strategic partnerships, especially in genomics, proteomics, and cell-based assays, ensuring our customers can effortlessly address all their needs in one centralized location,” said James Atwood, General Manager of Opentrons Robotics.

To learn more about Opentrons automation marketplace, please visit https://opentrons.com/automation-marketplace/

About Opentrons:

Opentrons Labworks, Inc., a disruptive life science company and the current market leader in entry-level lab automation, accelerates innovation in research and healthcare through its integrated lab platform, which includes business units Opentrons Robotics and Neochromosome. Opentrons has raised over $200 million in funding and achieved unicorn status based on its first- and second-generation robots, OT-One and OT-2. Opentrons Robotics provides thousands of institutions with flexible, easy-to-use lab robots, automating R&D operations and making robotics, a vast open-source library accessible to life sciences researchers worldwide. Opentrons is used in labs at the top 20 academic universities in the US and 14 of 15 leading global biopharmaceutical companies. Learn more at https://opentrons.com/.